- Home
- JPM vs LLY Comparison
JPM vs LLY Comparison
Compare JPM & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JPM
- LLY
- Stock Information
- Founded
- JPM 1799
- LLY 1876
- Country
- JPM United States
- LLY United States
- Employees
- JPM N/A
- LLY N/A
- Industry
- JPM Major Banks
- LLY Biotechnology: Pharmaceutical Preparations
- Sector
- JPM Finance
- LLY Health Care
- Exchange
- JPM Nasdaq
- LLY Nasdaq
- Market Cap
- JPM 687.5B
- LLY 684.4B
- IPO Year
- JPM N/A
- LLY N/A
- Fundamental
- Price
- JPM $294.80
- LLY $695.40
- Analyst Decision
- JPM Buy
- LLY Strong Buy
- Analyst Count
- JPM 15
- LLY 15
- Target Price
- JPM $302.93
- LLY $975.20
- AVG Volume (30 Days)
- JPM 7.6M
- LLY 7.0M
- Earning Date
- JPM 10-10-2025
- LLY 08-07-2025
- Dividend Yield
- JPM 1.90%
- LLY 0.86%
- EPS Growth
- JPM 8.70
- LLY 88.31
- EPS
- JPM 19.48
- LLY 15.29
- Revenue
- JPM $163,748,000,000.00
- LLY $53,258,100,000.00
- Revenue This Year
- JPM $9.14
- LLY $34.53
- Revenue Next Year
- JPM $2.70
- LLY $19.44
- P/E Ratio
- JPM $15.16
- LLY $45.47
- Revenue Growth
- JPM 1.71
- LLY 36.83
- 52 Week Low
- JPM $200.61
- LLY $623.78
- 52 Week High
- JPM $301.29
- LLY $972.48
- Technical
- Relative Strength Index (RSI)
- JPM 55.83
- LLY 43.38
- Support Level
- JPM $287.27
- LLY $685.15
- Resistance Level
- JPM $293.33
- LLY $719.46
- Average True Range (ATR)
- JPM 4.80
- LLY 21.95
- MACD
- JPM -0.08
- LLY 4.52
- Stochastic Oscillator
- JPM 79.84
- LLY 51.44
About JPM JP Morgan Chase & Co.
JPMorgan Chase is one of the largest and most complex financial institutions in the United States, with nearly $4.1 trillion in assets. It is organized into four major segments--consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. JPMorgan operates, and is subject to regulation, in multiple countries.
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.